(2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide

C31H31FN4O7 — CID 176753717

IUPAC(2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)[C@H]1CCCN1C(=O)CO)CC3
InChIInChI=1S/C31H31FN4O7/c1-3-31(42)18-9-23-27-16(11-36(23)29(40)17(18)13-43-30(31)41)26-20(34-28(39)22-5-4-8-35(22)24(38)12-37)7-6-15-14(2)19(32)10-21(33-27)25(15)26/h9-10,20,22,37,42H,3-8,11-13H2,1-2H3,(H,34,39)/t20-,22+,31-/m0/s1
InChIKeyGCXPCKHHPDDHMM-OSDLZFKDSA-N
MW590.61 g/mol
LogP1.61
Rot. Bonds4

About (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide

(2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide (PubChem CID 176753717) has the molecular formula C31H31FN4O7 and a molecular weight of 590.61 g/mol. Its IUPAC name is (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide
PubChem CID176753717
Molecular FormulaC31H31FN4O7
Molecular Weight590.61 g/mol
Exact Mass590.22
IUPAC Name(2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)[C@H]1CCCN1C(=O)CO)CC3
InChIInChI=1S/C31H31FN4O7/c1-3-31(42)18-9-23-27-16(11-36(23)29(40)17(18)13-43-30(31)41)26-20(34-28(39)22-5-4-8-35(22)24(38)12-37)7-6-15-14(2)19(32)10-21(33-27)25(15)26/h9-10,20,22,37,42H,3-8,11-13H2,1-2H3,(H,34,39)/t20-,22+,31-/m0/s1
InChIKeyGCXPCKHHPDDHMM-OSDLZFKDSA-N
XLogP1.61
TPSA151.06 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms43
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500590.61
LogP ≤ 51.61
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Analyze (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
The IUPAC name of (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide (CID 176753717) is (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide.
What is the SMILES notation for (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
The canonical SMILES for (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide is CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)[C@H]1CCCN1C(=O)CO)CC3.
What is the InChIKey of (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
The InChIKey is GCXPCKHHPDDHMM-OSDLZFKDSA-N. The full InChI is InChI=1S/C31H31FN4O7/c1-3-31(42)18-9-23-27-16(11-36(23)29(40)17(18)13-43-30(31)41)26-20(34-28(39)22-5-4-8-35(22)24(38)12-37)7-6-15-14(2)19(32)10-21(33-27)25(15)26/h9-10,20,22,37,42H,3-8,11-13H2,1-2H3,(H,34,39)/t20-,22+,31-/m0/s1.
What are the key properties of (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide?
(2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide has a molecular weight of 590.61 g/mol, XLogP of 1.61, 4 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide is sourced from PubChem (CID 176753717), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).